FDA May Revoke Immucor's Blood Reagent License
The Food and Drug Administration issued Immucor Inc. (Nasdaq: BLUD) a notice of intent to revoke the license for some blood reagents sending the stock price plunging $2.77 to $13.32.
The Food and Drug Administration issued Immucor Inc. (Nasdaq: BLUD) a notice of intent to revoke the license for some blood reagents sending the stock price plunging $2.77 to $13.32.
